These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28049862)

  • 21. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
    Gallo A; Passaro G; Gasbarrini A; Landolfi R; Montalto M
    World J Gastroenterol; 2016 Aug; 22(32):7186-202. PubMed ID: 27621567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Irritable bowel syndrome--irritable bowel or irritable mind?].
    Marlicz W; Zawada I; Starzyńska T
    Pol Merkur Lekarski; 2012 Jan; 32(187):64-9. PubMed ID: 22400184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic modulation of gut microbiota: current clinical applications and future perspectives.
    Ianiro G; Bibbò S; Gasbarrini A; Cammarota G
    Curr Drug Targets; 2014; 15(8):762-70. PubMed ID: 24909808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient diagnosis of suspected functional bowel disorders.
    Gunnarsson J; Simrén M
    Nat Clin Pract Gastroenterol Hepatol; 2008 Sep; 5(9):498-507. PubMed ID: 18679389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel perspectives on therapeutic modulation of the gut microbiota.
    McCarville JL; Caminero A; Verdu EF
    Therap Adv Gastroenterol; 2016 Jul; 9(4):580-93. PubMed ID: 27366225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Combined Live Probiotics Alleviating the Gastrointestinal Symptoms of Functional Bowel Disorders.
    Shi J; Gao F; Zhang J
    Gastroenterol Res Pract; 2020; 2020():4181748. PubMed ID: 33014039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Irritable Bowel Syndrome; gut microbiota and probiotic therapy].
    Tojo González R; Suarez Gonzalez A; Rúas Madiedo P; Mancebo Mata A; Pipa Muñiz M; Barreiro Alonso E; Roman Llorente FJ; Moro Villar MC; Arce González MM; Villegas Diaz MF; Mosquera Sierra E; Ruiz Ruiz M
    Nutr Hosp; 2015 Feb; 31 Suppl 1():83-8. PubMed ID: 25659060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. THE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a review.
    Moraes-Filho JP; Quigley EM
    Arq Gastroenterol; 2015 Dec; 52(4):331-8. PubMed ID: 26840477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
    Parkes GC; Brostoff J; Whelan K; Sanderson JD
    Am J Gastroenterol; 2008 Jun; 103(6):1557-67. PubMed ID: 18513268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.
    Foxx-Orenstein AE
    Therap Adv Gastroenterol; 2016 May; 9(3):354-75. PubMed ID: 27134665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy analysis of fecal microbiota transplantation in the treatment of 2010 patients with intestinal disorders].
    Li N; Tian HL; Chen QY; Yang B; Ma CL; Lin ZL; Zhang XY; Zhao D; Huang ZX; Jiang J; Qin HL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):861-868. PubMed ID: 31550826
    [No Abstract]   [Full Text] [Related]  

  • 32. Probiotics in irritable bowel syndrome: Where are we?
    Barbara G; Cremon C; Azpiroz F
    Neurogastroenterol Motil; 2018 Dec; 30(12):e13513. PubMed ID: 30460770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E; Monaldi L; Ricci P; Fiorucci S
    World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut Microbiota-Based Therapies for Irritable Bowel Syndrome.
    Stern EK; Brenner DM
    Clin Transl Gastroenterol; 2018 Feb; 9(2):e134. PubMed ID: 29446765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome.
    Wang Y; Zheng F; Liu S; Luo H
    Gastroenterol Res Pract; 2019; 2019():9759138. PubMed ID: 31885549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota].
    Fukudo S
    Brain Nerve; 2016 Jun; 68(6):607-15. PubMed ID: 27279158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of an oral synbiotic on the gastrointestinal immune system and microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Moser AM; Spindelboeck W; Halwachs B; Strohmaier H; Kump P; Gorkiewicz G; Högenauer C
    Eur J Nutr; 2019 Oct; 58(7):2767-2778. PubMed ID: 30251020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice.
    De Palma G; Lynch MD; Lu J; Dang VT; Deng Y; Jury J; Umeh G; Miranda PM; Pigrau Pastor M; Sidani S; Pinto-Sanchez MI; Philip V; McLean PG; Hagelsieb MG; Surette MG; Bergonzelli GE; Verdu EF; Britz-McKibbin P; Neufeld JD; Collins SM; Bercik P
    Sci Transl Med; 2017 Mar; 9(379):. PubMed ID: 28251905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome.
    Zhuang X; Tian Z; Li L; Zeng Z; Chen M; Xiong L
    Front Microbiol; 2018; 9():1600. PubMed ID: 30090090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.